NEWS RELEASE
FOR IMMEDIATE RELEASE 3/6/03
Contact: Paul Duesterhoft 817-900-4031
paul.duesterhoft@HEALTHPOINT.com
or call 800-441-8227


Dan Rippy Joins DFB, HEALTHPOINT® as
Director, New Business Development



       (Fort Worth, TX) — Paul Duesterhoft, Vice President, New Business Development of DFB Pharmaceuticals and its affiliate company, HEALTHPOINT Ltd., has announced that Daniel S. Rippy has joined DFB and HEALTHPOINT as Director, New Business Development.

        “Dan Rippy brings a tremendous amount of experience to our group,” said Mr. Duesterhoft. “We look forward to his contributions in expanding our technology, product, and service base as we drive our strategies toward an even stronger worldwide presence for the DFB companies.”

        As New Business Development Director, Mr. Rippy will search for, evaluate, coordinate and negotiate the acquisition or licensing of new services, brands, and technologies for DFB Pharmaceuticals and its affiliates, DPT Laboratories and HEALTHPOINT.

        “I am very excited about joining HEALTHPOINT, which clearly has the energy and appetite to grow its business,” said Mr. Rippy. “There are some very dynamic opportunities ahead, and I am looking forward to working with the HEALTHPOINT team to capitalize on them.”

        Most recently, Mr. Rippy was CEO of Macrocyclics, a Dallas-based, early stage specialty pharmaceutical company focused on next generation nuclear medicine and magnetic resonance imaging products. Mr. Rippy also held the business development positions with CellStar Corporation, Johnson & Johnson, and Bristol-Myers Squibb.

        A cum laude graduate from Macalester College in St. Paul, Minnesota, with Bachelor of Arts degrees in Political Science and Spanish, he received his Masters of Business Administration in Finance and Marketing from Columbia Business School in New York.

        Since its inception in 1992, HEALTHPOINT has established a U.S. presence in the research, development, and marketing of branded pharmaceuticals, over the counter drugs, and medical devices for tissue management, dermatology, and surgical. An aggressive research and development effort has brought HEALTHPOINT’s unique technologies to the market, setting the pace for its highly trained field sales organization of direct sales representatives. HEALTHPOINT, with over 250 employees, is a DFB Pharmaceuticals, Inc. affiliate company. Visit HEALTHPOINT’s web site at www.HEALTHPOINT.com. HEALTHPOINT is based in Fort Worth, Texas.

        Also headquartered in Fort Worth, DFB provides technology-driven products, outsourcing services and licensing opportunities to the healthcare industry worldwide through its affiliate companies, contract partners, and branded marketing organizations. DFB’s website is www.dfb.com

###